Indiana Univeristy Melvin and Bren Simon Cancer Center — Indianapolis, Indiana

Indiana Univeristy Melvin and Bren Simon Cancer Center is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Indiana Univeristy Melvin and Bren Simon Cancer Center has participated in 7 clinical trials with 1 currently active.

Therapeutic areas: NSCLC Stage IV, NSCLC, Recurrent, Non-Small Cell Lung Cancer.

Sponsors: Nasser Hanna, Lawrence Feldman, MD, Wake Forest University Health Sciences.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indiana Univeristy Melvin and Bren Simon Cancer Center?

Indiana Univeristy Melvin and Bren Simon Cancer Center has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indiana Univeristy Melvin and Bren Simon Cancer Center conducted?

Indiana Univeristy Melvin and Bren Simon Cancer Center has 7 clinical trials on record, with 1 currently active. Their work covers NSCLC Stage IV, NSCLC, Recurrent, Non-Small Cell Lung Cancer.

Is Indiana Univeristy Melvin and Bren Simon Cancer Center accredited by Crixeo Health?

Yes — Indiana Univeristy Melvin and Bren Simon Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Indiana Univeristy Melvin and Bren Simon Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.